TCM
TimesSquare Capital Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-500,920
| Closed | -$74.8M | – | 154 |
|
|
2024
Q3 | $74.8M | Sell |
500,920
-95,394
| -16% | -$14.2M | 1.12% | 25 |
|
|
2024
Q2 | $81.3M | Buy |
596,314
+20,616
| +4% | +$2.81M | 1.28% | 22 |
|
|
2024
Q1 | $87M | Sell |
575,698
-217,247
| -27% | -$32.8M | 1.27% | 19 |
|
|
2023
Q4 | $99.9M | Sell |
792,945
-49,856
| -6% | -$6.28M | 1.47% | 11 |
|
|
2023
Q3 | $78.9M | Buy |
842,801
+75,374
| +10% | +$7.06M | 1.23% | 16 |
|
|
2023
Q2 | $68.5M | Sell |
767,427
-84,653
| -10% | -$7.56M | 0.98% | 31 |
|
|
2023
Q1 | $91.4M | Buy |
852,080
+60,835
| +8% | +$6.52M | 1.34% | 9 |
|
|
2022
Q4 | $96.6M | Buy |
791,245
+151,570
| +24% | +$18.5M | 1.38% | 7 |
|
|
2022
Q3 | $66.1M | Buy |
639,675
+190,025
| +42% | +$19.6M | 0.92% | 22 |
|
|
2022
Q2 | $41.8M | Sell |
449,650
-50,800
| -10% | -$4.72M | 0.58% | 71 |
|
|
2022
Q1 | $58.7M | Sell |
500,450
-44,250
| -8% | -$5.19M | 0.66% | 57 |
|
|
2021
Q4 | $73.3M | Sell |
544,700
-39,700
| -7% | -$5.34M | 0.65% | 59 |
|
|
2021
Q3 | $93.1M | Buy |
584,400
+221,100
| +61% | +$35.2M | 0.81% | 32 |
|
|
2021
Q2 | $47.8M | Sell |
363,300
-103,000
| -22% | -$13.5M | 0.39% | 111 |
|
|
2021
Q1 | $60.1M | Buy |
466,300
+33,100
| +8% | +$4.27M | 0.51% | 80 |
|
|
2020
Q4 | $72.2M | Buy |
433,200
+1,340
| +0.3% | +$223K | 0.59% | 64 |
|
|
2020
Q3 | $66.6M | Buy |
431,860
+202,300
| +88% | +$31.2M | 0.62% | 52 |
|
|
2020
Q2 | $34M | Buy |
+229,560
| New | +$34M | 0.32% | 142 |
|